Tvm capital gmbh. The firm invested in companies operating in the biotech, pharmaceutical and medical technology sectors. The company has a highly experienced transatlantic investment team and approximately $900 million under management. and Heidelberg Innovation Gruppe for approximately €230 million on General Information Company Description Founded in 1983, TVM Capital was a venture capital firm based in Munich, Germany. Find company research, competitor information, contact details & financial data for TVM Capital GmbH of München, Bayern. John J Dibello is Former CFO:US Ops/COO/Gen Partner at Tvm Capital GmbH. It is one of the corporates which submit 10-K filings with the SEC. The Life Science Investment Group's mission is to invest in the development of exciting early stage drug candidates and Jun 9, 2016 · Dr. TVM strategically refocused in 2012 to best exploit untapped industry potential. Apr 22, 2024 · Munich, Germany and Montreal, Quebec, Canada (January 31, 2024) – TVM Capital Life Science (“TVM”), a leading transatlantic venture capital firm focused on investments in life sciences innovation, today announced the closing of a Series A financing round for Myosotis GmbH (“myo”), a pioneering Berlin-based digital healthcare startup. Their ground-breaking technology – SmartReports – delivers high-quality data in real time and at any scale. Security measures Apr 24, 2024 · Smart Reporting, a radiologist-founded technology startup, has raised nearly $25 million in new funding, leaders announced Monday. He currently serves as Chairman of the board of directors for leon nanodrugs GmbH and AL-S Pharma AG. The controller of this website The party responsible for processing your personal data on this website (in this policy referred to as “TVM”, “we” and/or “us”) is: TVM Life Science Management GmbH Ottostraße 4 80333 Munich Germany Telephone: +49 (89) 998 992-0 Email: info@tvm-capital. SEC Filings include 13F quarterly reports, 13D/G events and more. The Company invest in healthcare and technology companies. By investing in lasting partnerships, we have facilitated the development of leading products and services, recruited world-class management and gained a strong foothold in the North American and ImprintCopyright © 2025- TVM Capital Life Science Venture Capital leon-nanodrugs GmbH (LEON) is a technology provider specializing in equipment for the manufacturing of nanoparticle-based drug products, including RNA-based lipid nanoparticles (LNPs). Once cleared for clinical development by regulatory authorities, the Esperas Pharma Inc. Mar 16, 2023 · View TVM Capital (www. Seit 1984 hat TVM Capital Life Science in mehr als 130 Life-Science-Unternehmen in Europa, Kanada und den USA investiert und verwaltet derzeit mehr als 900 Millionen Euro von mehr als 50 Investoren. Find related and similar companies as well as employees by title and much more. Jan 31, 2024 · Munich, Germany and Montreal, Quebec, Canada (January 31, 2024) – TVM Capital Life Science (“TVM”), a leading transatlantic venture capital firm focused on investments in life sciences innovation, today announced the closing of a Series A financing round for Myosotis GmbH (“myo”), a pioneering Berlin-based digital healthcare startup. TVM Capital Life Science provides venture capital to international biopharmaceutical, medical technology, and diagnostic companies in North America and the EU. The Life Science Investment Group's mission is to invest in the development of exciting early stage drug candidates and The Life Science Investment Group of TVM Capital is providing venture capital to the international pharmaceutical, biopharmaceutical and medical technology industries with more than 25-years of transatlantic investment track record and in excess of US$1. We partner with management teams in Public filings of TVM V Life Science Ventures GmbH & Co KG raised by TVM Capital GmbH. Apr 22, 2024 · Smart Reporting, a leading technology provider in the field of medical reporting, has successfully completed a financing round of €23 million. Compare against similar firms. Founded in 2018, Myosotis GmbH (myo) offers the first software-as-a-service solution for direct digital communication between employees, relatives and the ecosystem of service providers in care homes. This trademark was filed to EUIPO on Tuesday, February 21, 2006. Munich, Germany-based TVM Capital Life Science led the Series C financing round with additional contributions from Bayern Kapital and existing investors. Tvm Capital is a venture capital company based in Munich, Germany. has been delivering international investment for over 30 years, and provides venture capital to the international pharmaceutical, biopharmaceutical, and medical technology industries. Oct 25, 2017 · The company has been backed by venture capital investors including funds managed by Xeraya Capital,TVM Capital Life Science, Wellington Partners, 360 Capital Partner and Heidelberg Innovation as well as by undisclosed family offices and private investors. C. Apr 22, 2024 · TVM Capital Life Science Leads €23 Million Series C Financing Round for Medical Reporting Technology Pioneer, Smart Reporting April 22, 2024 02:00 ET | Source: TVM Life Science Management GmbH Apr 22, 2024 · MUNICH, Germany and MONTREAL, April 22, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences The Life Science Investment Group of TVM Capital is providing venture capital to the international pharmaceutical, biopharmaceutical and medical technology industries with more than 25-years of transatlantic investment track record and in excess of US$1. The Life Science Investment Group's mission is to invest in the development of exciting early stage drug candidates and Aug 22, 2025 · TVM Capital GmbH in München Company founded 1995 Income Turnover Annual report Creditworthiness Management: Hubert Birner i. This Find contact information for TVM Capital. During his tenure with the TVM Capital group of companies, Dr. plans to begin clinical development as early as Q1-2016. 08, 2023 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences The Life Science Investment Group of TVM Capital is providing venture capital to the international pharmaceutical, biopharmaceutical and medical technology industries with more than 25-years of transatlantic investment track record and in excess of US$1. tvm-capital. com 3. Neurimmune and TVM Capital Life Science created AL-S Pharma AG to develop AP-101. They have less than $150 million in assets under management and operate 4 private funds. Learn about their Venture Capital & Private Equity, Finance market share, competitors, and TVM Capital's email format. View the latest funds and 13F holdings. a. . Oct 21, 2010 · Our mission is to invest in the development of exciting life science products and the growth of companies to become innovative leaders in their market segment. Nov 11, 2024 · SEC CIK TVM Capital GmbH's CIK is 0001342939 Past Insider Trading and Trends Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! Detailed Profile of TVM CAPITAL GMBH portfolio of holdings. TVM’s portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the Jul 8, 2021 · 2. Birner is responsible for TVM Capital Life Science’s overall investment strategy and global fund operations. Dr. About TVM Capital GmbH TVM Capital is a group of globally acting venture capital and private equity firms with an operating track record of 30 years. TVM CAPITAL GMBH specializes in: Investors, N. This business can be reached at (899) 989-920 Jan 31, 2024 · MUNICH, Germany and MONTREAL, Jan. 3 million investment from Impact Expansion, an impact driven European private equity firm based in Luxembourg with offices in Brussels and Paris and from existing neurocare shareholder TVM Capital Healthcare. TVM Capital is a trademark and brand of TVM Capital GmbH, München 80333, GERMANY. The app enables care facilities, families and service providers to communicate with each other easily, quickly and digitally. compound will be The Life Science Investment Group of TVM Capital is providing venture capital to the international pharmaceutical, biopharmaceutical and medical technology industries with more than 25-years of transatlantic investment track record and in excess of US$1. February 01, 2023 08:00 ET | Source: TVM Life Science Management GmbH Jan 31, 2024 · TVM Capital Life Science Announces €8 Million Investment in myo to Revolutionize Elderly Care via Innovative, Easy-to-Use App January 31, 2024 04:00 ET | Source: TVM Life Science Management GmbH TVM is a leading international venture capital firm focused on investing in life science innovations. Schühsler is currently the Chairman & Chief Executive Officer at TVM Capital Healthcare Partners Ltd. Jul 20, 2023 · About TVM Capital Life Science TVM Capital Life Science is a leading international venture capital firm focused on investing in life science innovations. Jan 18, 2022 · TVM Capital Life Science provides venture capital to international biopharmaceutical, medical technology, and diagnostic companies in North America and the EU. Sep 3, 2025 · Explore TVM Capital's in-depth investor profile, including top investments, portfolio trends, leadership team, co-investors, and news updates. Hubert Birner, Managing Partner at TVM Capital Life Science, added: “These promotions underscore TVM’s commitment to professional development and talent recognition. This manufacturer TVM Capital Life Science schafft nachhaltigen Wert - für Patienten, die Pharmaindustrie und unsere Investoren. Sep 25, 1995 · Company profile page for TVM Capital GmbH including stock price, company news, executives, board members, and contact information TVM Capital Life Science has emerged as one of the leading international venture capital firms in the field. TVM led the round, investing €8 million. Investment Team Operating Team ------ Operating Partners ------ Senior Advisors Platform Operations Team Aug 8, 2020 · TVM Capital GmbH, Munich, Germany, District Court of Munich HRB 110815: Earnings, Total assets, Revenue, Network, Financial information The Life Science Investment Group of TVM Capital is providing venture capital to the international pharmaceutical, biopharmaceutical and medical technology industries with more than 25-years of transatlantic investment track record and in excess of US$1. Aug 22, 2025 · Participation in, management of, and advising and providing other services to companies involved in the acquisition, management and sale of shareholdings in other companies, in particular innovative technology companies. This company currently has one owner. Track the AUM, funds, and holdings for TVM Capital GmbH over time. Schuehsler started biotech investing in Germany and made TVM Capital the leading and largest life science investor in Germany, led the development of the firm into one of the leading pan-European Oct 24, 2017 · Ambu A/S acquired invendo medical GmbH from Wellington Ventures, TVM Capital GmbH, 360° Capital Partners, Xeraya Capital Sdn Bhd. We work closely with our portfolio companies, striving to understand their ideas and enable them to develop their innovations to ultimately bring new therapies and medical technologies to market. The Life Science Investment Group's mission is to invest in the development of exciting early stage drug candidates and TVM Capital Healthcare is an emerging markets-focused healthcare private equity investment firm. 01, 2023 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading transatlantic venture capital firm focused on investments in life sciences TVM Capital GmbH investment firm profile page on Trusted Insight - the platform for institutional investors to discover investment jobs, talent, alternative investment news, syndicates and top investment managers rankings TVM Capital GmbH, München, Amtsgericht München HRB 110815: Gewinn, Bilanzsumme, Umsatz, Netzwerk, Wirtschaftsinfos TVM is a leading international venture capital firm focused on investing in life science innovations. The capital raised will primarily be used to expand product development Feb 21, 2023 · Montréal, Québec, February 21, 2023 – Esperas Pharma, Inc. AP-101 is a human antibody directed against misfolded superoxide dismutase 1 (SOD1). To achieve this, we adopted a dual-investment approach. 06, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences Free Business profile for TVM CAPITAL GMBH at Maximilianstr 35, Loveland, FC, 80539, DE. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. TVM Capital Life Science (lead investor) and Bayern Kapital are newly on board in the Series C funding, while the existing investors are also participating in the financing round. We invest equity capital into tech-enabled and transformational healthcare companies with ambitious growth plans in our key target regions. , Montréal, is a special purpose company created to develop one compound to proof-of-concept. Feb 1, 2023 · MONTREAL and MUNICH, Germany, Feb. The project is fully financed by TVM Life Science Innovation I L. Feb 5, 2025 · Munich, Brussels, Riyadh – February 5th, 2025 - neurocare group AG (“neurocare” or the “Company”), a leading mental health platform, is pleased to announce a EUR19. The investment will enable the company to execute on its growth plans, including TVM Capital Healthcare is a highly specialized healthcare expansion and growth capital investment firm operating out of offices in Dubai and Singapore. TVM’s portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the Feb 23, 2023 · Dr. Smart Reporting automates and streamlines medical documentation, which makes up to 40% of a physicians’ daily workload and creates valuable data in the process. Explore TVM Capital GmbH with its drug pipeline, therapeutic area, technology platform, 20 news, and 4 literature. Medical documentation currently occupies about 40% of a physician’s day, but Smart Reporting aims to address Apr 22, 2024 · Smart Reporting secures €23M in Series C funding led by TVM Capital Life Science and Bayern Kapital. He is also the Co-Chairman at Manzil Health Care Services LLC, Chairman at Bourn Hall LLC, and a Director at F-Star Biotechnologische Forschungs-. TVM’s portfolio focuses on therapeutics and medical technologies from North He started his investment management career at Horizonte Venture Management in Vienna, Austria, and joined TVM Capital in Munich in 1990. Prior to TVM, Amy focused on building and funding healthtech opportunities at Oxford Science Enterprises, the largest university-affiliated investment company in the world. This is based on reported shares across multiple companies, which include Jun 9, 2016 · Dr. TVM follows a two-pronged strategy with a focus on early-stage and late-stage investments. He received his doctorate degree from the University of Freiburg. Our investment teams have fi Tvm Capital is a Trademark by Tvm Life Science Management Gmbh, the address on file for this trademark is Ottostraße 4, Munich 80333 Apr 24, 2024 · TVM Capital Healthcare Announces US$ 17 Million Investment into neurocare neurocare is revolutionizing mental health care by providing innovative methods and tools based on neurostimulation and other technologies to help clinicians deliver personalized treatments with sustainable clinical outcomes for patients. Find out about his known public assets. You can view more information on Tvm Capital including private fund info, contact info, top management and executives, website, email addresses, and more below: Mar 7, 2014 · Who is TVM Capital GmbH TVM Capital GmbH does not have any significant net worth to report based on the numbers we have. This trademark was filed to EUIPO on Monday, July 7, 2008. TVM Capital Life Science is a group of independent investment advisories and fund managers for Venture Capital funds, investing into biotech, pharmaceutical, and MedTech TVM BioCapital is a trademark and brand of TVM Capital GmbH, München 80333, GERMANY. The organization invests growth capital and focuses on specialized healthcare services, digital Corporate information Official name TVM Capital GmbH Registration country Germany The Life Science Investment Group of TVM Capital is providing venture capital to the international pharmaceutical, biopharmaceutical and medical technology industries with more than 25-years of transatlantic investment track record and in excess of US$1. See John J Dibello's compensation, career history, education, & memberships. , General Partner by TVM Capital GmbH, Director-Supervisory Board by invendo medical GmbH, and Member-Supervisory Board by Probiodrug AG. You can view more information on Tvm Capital including private fund info, contact info, top management and executives, website, email addresses, and more below: Find company research, competitor information, contact details & financial data for TVM Capital GmbH of München, Bayern. 1bn under management. Polack was previously employed as Independent Director by bluebird bio, Inc. Currently, safety, tolerability, pharmacokinetics and pharmacodynamics of AP-101 are assessed in patients with ALS. The financing was led by TVM Capital Life Science, based in Munich and Montreal, with participation The Life Science Investment Group of TVM Capital is providing venture capital to the international pharmaceutical, biopharmaceutical and medical technology industries with more than 25-years of transatlantic investment track record and in excess of US$1. Esperas is developing the first oral Check 1 inhibitor, ESP-001 (formerly LY2880070), a . 5 million. Oct 16, 2025 · About TVM Capital Life Science TVM is a leading international venture capital firm focused on investing in life science innovations. The Company funds operate globally with dedicated life science venture capital funds. The firm seeks to invest in biopharma, diagnostic, med-tech and digital health companies in Europe, North America and Asia. Oct 27, 2020 · /PRNewswire/ -- TVM Capital Life Science, one of the leading life sciences venture capital firms in North America and Europe, today announced the final closing Original document: “Gesellschaftsvertrag / Satzung / Statut“ 6 Dec 2017 via TVM Capital GmbH Shareholder: TVM Capital GmbH 13 Oct 2017 as NewCo 2008 GmbH Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016 TVM Life Science Innovation I. Tvm Life Science Management Gmbh has an ownership stake in Tvm Capital of more than 75%. E. Jun 9, 2016 · Stefan Fischer joined TVM Capital in 2000 and is General Partner and CFO of TVM Capital in Munich, responsible for the corporate finance. The Jun 29, 2024 · TVM Capital Life Science is a dedicated life science venture capital firm, with offices in Montreal, Canada and Munich, Germany. LEON’s technology platform, featuring the modular FR-JET ® mixing reactor, enables a seamless transition from R&D to commercial-scale manufacturing, eliminating common challenges associated with tech transfer Oct 7, 2021 · Founded in 1984, TVM Capital Life Science is a venture capital firm based in Munich, Germany. Feb 1, 2023 · TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc. Discovery Company profile page for TVM Capital GmbH including technical research,competitor monitor,market trends,company profile& stock symbol TVM Capital GmbH is a Germany-based venture capital and private equity fund. (“Esperas”), a company based in Montréal, Québec, today announced a follow-on investment by TVM Capital Life Science (“TVM”) through its fund TVM Life Science Innovation I SCSp and the Fonds de solidarité FTQ (the “Fonds”). com) location in Bavaria, Germany , revenue, industry and description. Feb 8, 2023 · TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients February 08, 2023 08:00 ET | Source: TVM Life Science Management GmbH Feb 8, 2023 · MONTREAL and MUNICH, Germany, Feb. As true partners, we work closely with our portfolio companies, striving to enable their ideas and bring new therapies and medical products to market. Growing the next Nov 15, 2024 · Neuigkeit zur TVM Capital GmbH Erhalten Sie aktuelle Neuigkeiten und wichtige Informationen, einschließlich Managementwechsel, Bonitätsveränderungen und Änderungen der Besitzverhältnisse. Sep 10, 2011 · TVM Capital Healthcare is a highly specialized healthcare expansion and growth capital investment firm operating out of offices in Dubai and Singapore. Get the latest business insights from Dun & Bradstreet. Private Equity Analyst at TVM Capital GmbH, Discover Philipp Lechner's known position history, network and 12 relationships. We invest equity capital into tech-enabled and transformational healthcare companies with ambitious growth plans in our key target regions: the Middle East and North Africa (MENA) region and Southeast Asia. The Life Science Investment Group's mission is to invest in the development of exciting early stage drug candidates and Esperas Pharma Inc. 3 million investment in neurocare group AG, a Munich-based personalized mental health care provider. The employer identification number (EIN) for Tvm Capital Gmbh is 300248831. Feb 6, 2024 · MUNICH, Germany and MONTREAL, Feb. Amy Kao joined TVM Capital in April 2023. Sep 25, 1995 · Company profile page for TVM Capital GmbH including stock price, company news, executives, board members, and contact information Sep 3, 2025 · Explore TVM Capital's in-depth investor profile, including top investments, portfolio trends, leadership team, co-investors, and news updates. Amy was previously a management consultant at EY Global, advising transaction strategies for health care & life science Feb 10, 2025 · Morgan Lewis represented TVM Capital Healthcare as co-investor on a €19. Dec 3, 2015 · Dürr Aktiengesellschaft acquired iTAC Software AG from TVM Capital GmbH, Sapphire Ventures LLC, EVP Capital Management AG, Pari Capital GmbH, Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft Tvm Life Science Management Gmbh is a foreign entity serving as Shareholder for Tvm Capital, a venture capital company. 31, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading transatlantic venture capital firm focused on investments in life sciences Jul 27, 2015 · TVM Capital Life Science leads international syndicate of investors – an additional EUR 3 million investment is expected later in 2015Munich, 27 July 2015 — leon nanodrugs GmbH today announced that it completed the first closing of its Series A preferred stock offering at EUR 18. Esperas Pharma Inc. Helmut M. Direct links to the EDGAR source material. and Fonds de solidarité FTQ. The Life Science Investment Group's mission is to invest in the development of exciting early stage drug candidates and Aug 15, 2011 · TVM Capital GmbH, Munich, Germany, District Court of Munich HRB 110815: Earnings, Total assets, Revenue, Network, Financial information Discovery Company profile page for TVM Capital GmbH including technical research,competitor monitor,market trends,company profile& stock symbol Trademark registration by TVM Life Science Management GmbH for the trademark TVM CAPITAL. The Life Science Investment Group's mission is to invest in the development of exciting early stage drug candidates and TVM Capital Life Science is an international venture capital firm with a focus on investments in life science innovations. Smart Reporting is one of the leading technology providers in the field of medical reporting. L. Barclays is acting as exclusive financial advisor to the shareholders of invendo medical. P. TVM Capital Life Science Venture Capital and Private Equity Principals Germany 11-50 Employees TVM is a leading international venture capital firm focused on investing in life science innovations. Tvm Capital Gmbh is a corporation in Munchen, 2M. aopcexb axg wo nomaaw 7oz5aqd j20c mwn lvgm nno 8bhxevwyq